Everlum Bio

Our mission at Everlum Bio is clear: to transform drug discovery and provide provide direct-to-patient cures. Our Cure Plan helps families impacted by a rare disease by giving them answers and hope. We've designed this program so that families don’t need to become scientists or project managers. Everlum handles it all. The second phase of our Cure Plan focuses on Genetic Sequencing. Whole Exome Sequencing (WES) is essential for diagnosing rare genetic disorders and helping families understand the genetic causes of health issues. Long-read sequencing provides a detailed view of the genome, identifying disease-causing variants and accelerating targeted therapies. Contact us at everlum.bio to learn more about our transformative approach and how it can help you.

Unlock the Path to a Cure with Everlum Bio’s Cure Map! Understanding diseases and finding effective treatments is crucial for drug development. With our Cure Map program, you get an in-depth Amenability Study delivered in under 3 months! This comprehensive study explores the disease, evaluates potential treatments, and identifies the most promising path forward. Plus, we revisit this study every quarter to stay at the cutting edge of scientific advancements. At Everlum Bio, our mission is to innovate personalized direct-to-patient cures. Take Action Now: Click the link to learn more about how our Cure Map can accelerate your drug development process and lead to your breakthrough treatments! everlum.bio #CureMap #DrugDevelopment #PersonalizedMedicine

At Everlum, our mission is to transform drug discovery by providing exceptional management of drug development, research, and data. Our pre-clinical Toolbox uses Induced Pluripotent Stem Cell (iPSC) technology to develop patient-specific cell lines, helping us create accurate disease models and test treatments tailored to individual genetic backgrounds. This personalized approach increases successful outcomes and significantly speeds up drug discovery. Visit everlum.bio to contact us for more information and see how Everlum can guide you on your journey to a cure! #RareDisease #DrugDiscovery#PersonalizedMedicine

What if you could change a life every month? 🌟 Join our monthly donors and make a lasting impact today! 💙 When we started this journey, we believed finding researchers would be nearly impossible. But luck and circumstance intervened and allowed the family to add to your contributions the additional $140,000 needed for the research project. We began with three groups of researchers eager to study Casey's genes. Now we have seven. Science is eager to learn how this gene works. Quite a success, isn't it? But we need your help. We need your help now. Please think about making a monthly donation to help us support these researchers who hold the key to making Casey's Cure a reality. Without you, the science stops. Please give today. https://lnkd.in/ezxfVqCs #MonthlyDonors #ImpactToday #ResearchProject #GeneticResearch #MedicalScience #CaseysCure #DonateNow #SupportResearchers #MedicalBreakthrough #MonthlyGiving

At Everlum Bio, we believe in revolutionizing the therapeutic discovery process, for you. Not only do we implement a Centralized Data storage plan, but the patient owns all their data from the beginning. This secure and easily accessible hub houses all disease-related data, research findings, and our drug development records. We promote collaboration, knowledge sharing, and efficient decision-making by granting access to our partners and researchers. Our mission is to transform the rare disease community through our cutting-edge Drug Discovery as a Service plan. With this program, parents and families no longer need to be scientists, business owners, researchers, and project managers—we're here to take on that role and so much more. Together, we can make a difference! Get more info by contacting us here at everlum.bio! #DrugDiscovery #RareDiseases #Collaboration #Innovation #PersonalizedMedicine

Grateful for the highlight 🤩 Michael Morgenstern & Brex!

The Road to a Cure Starts Here! At Everlum, we’re on a mission to innovate and deliver personalized direct-to-patient cures. Our Drug Discovery as a Service Plan is designed to take the burden off parents and families. No need to be scientists, researchers, or project managers—we’ve got you covered. Our dedicated science team ensures seamless collaboration and coordination among our team and with external researchers. Together, we accelerate scientific breakthroughs and bring hope to families everywhere. Let Everlum be your guide on the journey to a cure…contact us here to talk about how! everlum.bio #RareDisease #DrugDiscovery#PersonalizedMedicine

Exciting Breakthrough in Gene Therapy! We are thrilled to announce that Everlum Bio has just filed a patent for our groundbreaking SPG11 Gene Therapy treatment! This innovative drug represents a significant leap forward in our mission to cure rare diseases. Mutations in the SPG11 gene result in a debilitating and ultimately deadly rare genetic disorder that has long been a challenging condition with only palliative treatment options. Our new gene therapy aims to provide hope and improved quality of life for those affected.   Key Highlights - Advanced Research:  In Less than a year Everlum Bio has differentiated neurons from patient-derived tissue, designed and grown a gene therapy vector, and dosed those patient-derived neurons demonstrating correction of the lysosomal storage disorder, and correction of disease. -In collaboration with an amazing team at Jackson Laboratories a humanized mouse with mutations in SPG11 was created. This gene therapy will next be tested on this mouse. This will significantly shortcut the development process of this gene therapy, getting it to the patient faster. - Patient-Centric Approach: The Gene Therapy from Everlum Bio is designed to address the underlying genetic cause, offering a potentially transformative impact on patients' lives. We started the process by looking for a treatment for our patient but ended up with a treatment that could benefit all with SPG11-related disease. This work may pave the way for developing other gene therapies for more SPGX-related disorders. - Collaboration & Innovation: This achievement is a testament to the hard work and collaboration of our incredible team of scientists, researchers, and partners.   We remain committed to pushing the boundaries of personalized medicine and bringing life-changing treatments to those who need them. Stay tuned for more updates as we continue our journey to make a difference in the world of rare diseases.   #EverlumBio #JacksonLaboratories #GeneTherapy #SPG11 #BiotechInnovation #HealthcareRevolution #ScientificBreakthrough #PatientCare #PersonalizedMedicine

We're #hiring. Know anyone who might be interested? Everlum is a fast growing biotech seeking to make therapeutics available for families impacted by a rare uncured disease, and that is just the start!

Ready to share and colloborate with all at the Global Genes Rare Drug Development Symposium, Everlum looks forward to connecting with all the amazing folks in the rare disease community. @globalgenes #rdds #globalgenes #orphandisease #everlum